secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ainos, Inc. (AIMD)
CIK:        0001014763
Form:       8-K
Filed at:   2024-10-22T23:59:59+00:00
Accession:  0001493152-24-042062
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ainos adds exclusive patent rights and co-development of nitrogen-oxygen separation machine with TCNT
--------------------------------------------------------------------------------

- Third Addendum to Product Development Agreement adds nitrogen-oxygen separation machine for medical oxygen and wound healing.
- TCNT grants Ainos exclusive sales rights and full patent authorization for the new machine.
- Exclusive patent use fee set at $50,000/month plus 5% sales tax for one year starting October 16, 2024.
- TCNT controls ~62.9% of Ainos voting power as of October 17, 2024.
- Co-development scope expanded to include VELDONA drug pre-processing and manufacturing development.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1014763/000149315224042062/0001493152-24-042062-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1014763/000149315224042062/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-042062

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer